Low vitamin D linked to schizophrenic brain dysfunction

By Annie Harrison-Dunn contact

- Last updated on GMT

Study finds 97% of schizophrenic participants have sub-optimal vitamin D serum levels
Study finds 97% of schizophrenic participants have sub-optimal vitamin D serum levels

Related tags: Central nervous system, Vitamin d

Vitamin D deficiency may be linked to the dysfunction of the hippocampus – a region of the brain thought to play a role in schizophrenia, say researchers.

Researchers from the National Institute of Mental Health and Neuroscience (NIMHANS) in India and the Harvard Medical School in the US looked at the serum vitamin D levels and the brain of 35 schizophrenia patients with an average age of 32.

They found 34 of the patients had sub-optimal levels of serum vitamin D - 83% of which equated to deficiency and 14% insufficiency.

A “significant positive correlation”​ was also seen between vitamin D and regional grey matter volume in the right hippocampus.

Previous research had suggested vitamin D supplementation may reduce the risk of schizophrenia in infants while another paper linked deficient serum levels with first-episode psychosis.

However this latest paper was the first to look at serum vitamin D levels and hippocampal volume in schizophrenia.

The hippocampus is one of the brain regions with maximum concentrations of vitamin D receptors and the vitamin has been shown to play a critical role in hippocampal cell survival through its neuroprotective effects.

They said the relationship could be due to vitamin D’s impact on neuron-supporting neurotrophin proteins, the nervous system’s interaction with the immune system and the excretion of amino acids.

“Since deficient brain-derived neurotrophic factor and increased oxidative stress have been associated with schizophrenia, these effects mediated by vitamin D through vitamin D receptors could be critical in this disorder,” ​the wrote in Psychiatry Research: Neuroimaging. 

The hippocampus - named after its resemblance to a seahorse - is thought to play a key role in emotions and memory. 

Source: Psychiatry Research: Neuroimaging
Vol. 233, Iss. 2, pp. 175–179, doi:10.1016/j.pscychresns.2015.06.006
“Serum vitamin D and hippocampal gray matter volume in schizophrenia”
Authors: V. Shivakumar, S. V. Kalmady, A. C. Amaresha, D. Jose, J. C. Narayanaswamy, S. Mahavir Agarwal, B. Joseph, G. Venkatasubramanian, V. Ravi, M. S. Keshavan and B. N. Gangadhar

Related news

Show more

Related products

show more

WHERE THE WORLD IS GOING NEXT FOR VITAMIN D

WHERE THE WORLD IS GOING NEXT FOR VITAMIN D

PLT Health Solutions | 22-Jun-2022 | Product Brochure

Earthlight® Whole Food Vitamin D is a clean label ingredient that can help you create cutting-edge fortified foods and supplements. Low use levels mean...

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Happier with indication-specific probiotics

Happier with indication-specific probiotics

Winclove Probiotics | 07-Jun-2022 | Product Brochure

From the very founding of Winclove Probiotics, our aim to help people, society, and the world has been an essential part of our business DNA.

Stronger Bones Begin with MenaQ7® Vitamin K2

Stronger Bones Begin with MenaQ7® Vitamin K2

Gnosis by Lesaffre | 06-Jun-2022 | Infographic

By activating the K-dependent protein Osteocalcin, Vitamin K2 as MK-7 enables the body to properly utilize calcium, binding it to the bone matrix.

Related suppliers

Follow us

Products

View more

Webinars